BODYCOTE PLC |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 704 GBX | +1.15% |
|
+1.22% | +18.50% |
| 01/05 | EXECUTIVE CHANGES: New chairs for CVS Group, LSL Property and Videndum | AN |
| 03/04 | Jefferies Raises Bodycote PT, Maintains Buy Rating | MT |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 1,806 | 1,417 | 1,650 | 1,084 | 1,134 | 1,305 | - | - |
| Enterprise Value (EV) 1 | 1,865 | 1,515 | 1,766 | 1,184 | 1,186 | 1,421 | 1,378 | 1,341 |
| P/E ratio | 19.3 x | 3,728 x | 27.7 x | 14.7 x | 13.3 x | 14.6 x | 12.5 x | 10.9 x |
| Yield | 2.1% | 2.6% | 2.31% | 3.75% | 3.82% | 3.48% | 3.71% | 4.02% |
| Capitalization / Revenue | 2.51 x | 2.37 x | 2.68 x | 1.46 x | 1.41 x | 1.61 x | 1.54 x | 1.45 x |
| EV / Revenue | 2.59 x | 2.53 x | 2.87 x | 1.59 x | 1.48 x | 1.75 x | 1.62 x | 1.49 x |
| EV / EBITDA | 8.88 x | 9.58 x | 10.5 x | 6.23 x | 5.96 x | 6.53 x | 5.82 x | 5.2 x |
| EV / FCF | 18.7 x | 25 x | 17.8 x | 13.8 x | - | 15.9 x | 13.7 x | 12.8 x |
| FCF Yield | 5.34% | 4% | 5.62% | 7.24% | - | 6.28% | 7.32% | 7.82% |
| Price to Book | 2.56 x | 2.09 x | 2.4 x | 1.39 x | 1.43 x | 1.64 x | 1.52 x | 1.39 x |
| Nbr of stocks (in thousands) | 1,89,752 | 1,90,051 | 1,90,591 | 1,90,710 | 1,90,817 | 1,87,455 | - | - |
| Reference price 2 | 9.520 | 7.455 | 8.655 | 5.685 | 5.945 | 6.960 | 6.960 | 6.960 |
| Announcement Date | 12/03/20 | 12/03/21 | 14/03/22 | 17/03/23 | 15/03/24 | - | - | - |
1GBP in Million2GBP
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 719.7 | 598 | 615.8 | 743.6 | 802.5 | 810.4 | 848.7 | 901.5 |
| EBITDA 1 | 209.9 | 158.1 | 168.5 | 190.1 | 198.9 | 217.4 | 236.5 | 258.1 |
| EBIT 1 | 134.9 | 75.3 | 94.8 | 112.2 | 127.6 | 136.6 | 152.5 | 170.5 |
| Operating Margin | 18.74% | 12.59% | 15.39% | 15.09% | 15.9% | 16.86% | 17.96% | 18.92% |
| Earnings before Tax (EBT) 1 | 123.9 | -1.5 | 77.5 | 95.3 | 111.7 | 121 | 139.9 | 158.2 |
| Net income 1 | 93.8 | 0.4 | 59.5 | 73.7 | 85.6 | 88.24 | 101 | 114 |
| Net margin | 13.03% | 0.07% | 9.66% | 9.91% | 10.67% | 10.89% | 11.89% | 12.65% |
| EPS 2 | 0.4920 | 0.002000 | 0.3120 | 0.3860 | 0.4480 | 0.4758 | 0.5564 | 0.6395 |
| Free Cash Flow 1 | 99.6 | 60.6 | 99.2 | 85.7 | - | 89.2 | 100.8 | 104.9 |
| FCF margin | 13.84% | 10.13% | 16.11% | 11.53% | - | 11.01% | 11.88% | 11.64% |
| FCF Conversion (EBITDA) | 47.45% | 38.33% | 58.87% | 45.08% | - | 41.02% | 42.63% | 40.65% |
| FCF Conversion (Net income) | 106.18% | 15,150% | 166.72% | 116.28% | - | 101.09% | 99.88% | 91.99% |
| Dividend per Share 2 | 0.2000 | 0.1940 | 0.2000 | 0.2130 | 0.2270 | 0.2423 | 0.2583 | 0.2796 |
| Announcement Date | 12/03/20 | 12/03/21 | 14/03/22 | 17/03/23 | 15/03/24 | - | - | - |
1GBP in Million2GBP
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2019 S2 | 2020 S1 | 2020 S2 | 2021 S1 | 2021 S2 | 2022 S1 | 2023 S1 |
|---|---|---|---|---|---|---|---|
| Net sales 1 | 353.2 | 306.7 | 291.3 | 312.9 | 302.9 | 358.5 | 420.1 |
| EBITDA | - | - | - | 83.9 | 84.6 | - | - |
| EBIT 1 | 68 | 37.8 | 37.5 | 48.7 | 46.1 | 50.5 | 62.8 |
| Operating Margin | 19.25% | 12.32% | 12.87% | 15.56% | 15.22% | 14.09% | 14.95% |
| Earnings before Tax (EBT) | - | - | - | - | - | - | - |
| Net income | - | - | - | - | - | - | - |
| Net margin | - | - | - | - | - | - | - |
| EPS | - | - | - | - | - | - | - |
| Dividend per Share 2 | - | 0.0600 | - | 0.0620 | 0.1380 | - | 0.0670 |
| Announcement Date | 12/03/20 | 23/07/20 | 12/03/21 | 29/07/21 | 14/03/22 | 29/07/22 | 27/07/23 |
1GBP in Million2GBP
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net Debt 1 | 58.5 | 98.1 | 116 | 99.4 | 51.7 | 116 | 72.9 | 36.2 |
| Net Cash position 1 | - | - | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | 0.2787 x | 0.6205 x | 0.6908 x | 0.5229 x | 0.2599 x | 0.5339 x | 0.3083 x | 0.1401 x |
| Free Cash Flow 1 | 99.6 | 60.6 | 99.2 | 85.7 | - | 89.2 | 101 | 105 |
| ROE (net income / shareholders' equity) | 13.9% | 7.64% | 10% | 7.57% | 10.9% | 11.8% | 13.1% | 13.5% |
| ROA (Net income/ Total Assets) | 9.54% | 4.95% | 6.3% | 7.02% | 7.43% | 7.95% | 8.73% | 9.06% |
| Assets 1 | 983.7 | 8.081 | 944.4 | 1,050 | 1,152 | 1,110 | 1,157 | 1,259 |
| Book Value Per Share 2 | 3.710 | 3.570 | 3.600 | 4.080 | 4.140 | 4.230 | 4.590 | 5.020 |
| Cash Flow per Share 2 | 0.9300 | 0.7700 | 0.7600 | 0.7500 | 1.000 | 0.9800 | 1.080 | 1.160 |
| Capex 1 | 77.7 | 58 | 45.1 | 57.2 | 74.1 | 82.9 | 82.4 | 83.5 |
| Capex / Sales | 10.8% | 9.7% | 7.32% | 7.69% | 9.23% | 10.23% | 9.71% | 9.26% |
| Announcement Date | 12/03/20 | 12/03/21 | 14/03/22 | 17/03/23 | 15/03/24 | - | - | - |
1GBP in Million2GBP
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
6.96
GBP
Average target price
8.005
GBP
Spread / Average Target
+15.01%
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +18.50% | 1.64B | |
| +12.65% | 84.97B | |
| +19.56% | 70.8B | |
| +14.40% | 35.7B | |
| +21.72% | 33.75B | |
| +13.41% | 28.72B | |
| +4.55% | 27.1B | |
| +3.90% | 26.02B | |
| +20.37% | 25.7B | |
| +18.15% | 24.98B |
- Stock Market
- Equities
- BOY Stock
- Financials Bodycote plc